通过联邦医疗保险和医疗补助计划改善饮食与健康的财务激励的成本效益:一项微观模拟研究
水果蔬菜30%补贴和更广泛健康食品30%补贴均能在终身内预防心血管疾病和糖尿病、获得质量调整生命年并节省正规医疗费用,且从医疗保健和社会角度均具成本效益。
要点
- 两种补贴从医疗保健角度终身增量成本效益比分别为18184美元/质量调整生命年和13194美元/质量调整生命年,从社会角度分别为14576美元/质量调整生命年和9497美元/质量调整生命年。
核心结论
- 通过联邦医疗保险和医疗补助计划对更健康食品提供经济激励可产生显著健康获益且极具成本效益。
研究设计与样本
- 比较两种政策情景与无新干预的基线:水果蔬菜30%补贴和包括水果蔬菜、全谷物、坚果/种子、海产品及植物油在内的更广泛健康食品30%补贴。
- 模型输入包括2009至2014年美国国家健康与营养调查(NHANES)的人口与饮食数据、荟萃分析的政策效应与饮食-疾病效应以及既定来源的政策与健康相关成本。
主要发现
- 研究人群平均(标准差)年龄68.1(11.4)岁,女性占56.2%,非白人占25.5%。
- 从医疗保健角度,两种情景在5年及以上均具成本效益,终身增量成本效益比分别为18184美元/质量调整生命年(水果蔬菜补贴)和13194美元/质量调整生命年(健康食品补贴)。
- 从社会角度(包括非正规医疗费用和生产力损失),相应增量成本效益比分别为14576美元/质量调整生命年和9497美元/质量调整生命年。
关键数值与推荐
- 水果蔬菜30%补贴:终身增量成本效益比18184美元/质量调整生命年(医疗保健角度),14576美元/质量调整生命年(社会角度)。
- 健康食品30%补贴:终身增量成本效益比13194美元/质量调整生命年(医疗保健角度),9497美元/质量调整生命年(社会角度)。
- 结果在概率敏感性分析以及一系列单因素敏感性和亚组分析中稳健,包括干预持续时间(5年、10年、20年和终身)、食品补贴水平(20%、50%)、保险组别(联邦医疗保险、医疗补助和双重资格)以及各保险组内受益人特征。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 此类模拟研究提供获益与不确定性的定量估计,但不能直接证明健康与经济影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Economic incentives through health insurance may promote healthier behaviors. Little is known about health and economic impacts of incentivizing diet, a leading risk factor for diabetes and cardiovascular disease (CVD), through Medicare and Medicaid. METHODS AND FINDINGS: A validated microsimulation model (CVD-PREDICT) estimated CVD and diabetes cases prevented, quality-adjusted life years (QALYs), health-related costs (formal healthcare, informal healthcare, and lost-productivity costs), and incremental cost-effectiveness ratios (ICERs) of two policy scenarios for adults within Medicare and Medicaid, compared to a base case of no new intervention: (1) 30% subsidy on fruits and vegetables ("F&V incentive") and (2) 30% subsidy on broader healthful foods including F&V, whole grains, nuts/seeds, seafood, and plant oils ("healthy food incentive"). Inputs included national demographic and dietary data from the National Health and Nutrition Examination Survey (NHANES) 2009-2014, policy effects and diet-disease effects from meta-analyses, and policy and health-related costs from established sources. Overall, 82 million adults (35-80 years old) were on Medicare and/or Medicaid. The mean (SD) age was 68.1 (11.4) years, 56.2% were female, and 25.5% were non-whites. Health and cost impacts were simulated over the lifetime of current Medicare and Medicaid participants (average simulated years = 18.3 years). The F&V incentive was estimated to prevent 1.93 million CVD events, gain 4.64 million QALYs, and save $39.7 billion in formal healthcare costs. For the healthy food incentive, corresponding gains were 3.28 million CVD and 0.12 million diabetes cases prevented, 8.40 million QALYs gained, and $100.2 billion in formal healthcare costs saved, respectively. From a healthcare perspective, both scenarios were cost-effective at 5 years and beyond, with lifetime ICERs of $18,184/QALY (F&V incentive) and $13,194/QALY (healthy food incentive). From a societal perspective including informal healthcare costs and lost productivity, respective ICERs were $14,576/QALY and $9,497/QALY. Results were robust in probabilistic sensitivity analyses and a range of one-way sensitivity and subgroup analyses, including by different durations of the intervention (5, 10, and 20 years and lifetime), food subsidy levels (20%, 50%), insurance groups (Medicare, Medicaid, and dual-eligible), and beneficiary characteristics within each insurance group (age, race/ethnicity, education, income, and Supplemental Nutrition Assistant Program [SNAP] status). Simulation studies such as this one provide quantitative estimates of benefits and uncertainty but cannot directly prove health and economic impacts. CONCLUSIONS: Economic incentives for healthier foods through Medicare and Medicaid could generate substantial health gains and be highly cost-effective.
引用
- Lee Y, Mozaffarian D, Sy S, et al. Cost-effectiveness of financial incentives for improving diet and health through Medicare and Medicaid: A microsimulation study. PLoS Med. 2019. PMID: 30889188. doi:10.1371/journal.pmed.1002761
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。